In addition to studying the correlations between TDP-43 and cognitive decline, cohort studies have also evaluated the relationship between TDP-43 and the neuropathologic hallmarks of AD, amyloid and tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.